Evonik says ‘go’ — even though Greece might say ‘no’
The decision to launch the €3.5bn-€5bn IPO of Evonik on Friday morning generated mixed reviews from ECM bankers with some worried that Europe’s flagship transaction will be a hostage to market and political sentiment. But there was also plenty of conviction that it is the right deal to bring to market now.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts